Search results
Found 165 matches for
Oxford, UK: 23 May, 2018: Orbit Discovery Ltd, an Oxford, UK-based biotech company developing an industry-leading peptide identification and optimisation platform, today announced the closing of a £6.9M Series A Financing. The round was led by Oxford Sciences Innovation who were joined by new investors RT Ventures, Borealis Ventures, Perivoli Innovations, along with further investment from all existing investors and Oxford University. Additionally, Borealis Managing Partner Phil Ferneau and Oxford Investment Consultants’ Partner James Mallinson join Orbit’s Board of Directors.
Chris Groves
Administration IMD MRC MHU Research Support WIMM
BSc (Hons) Chris Groves - MRC MHU Laboratory Manager
Simon Davis
IMD MRC TIDU Principal Investigators
BSc (Hons), PhD Simon Davis - Professor of Molecular Immunology
Alain Townsend
Emeritus Professors IMD MRC TIDU WIMM
FRS FRCP Alain Townsend - Emeritus Professor of Molecular Immunology
Timothy Rostron
IMD MRC TIDU Research Support
BSc; MSc Timothy Rostron - Sequencing and HLA Typing Laboratory Manager
Jan Rehwinkel
IMD MRC TIDU Principal Investigators
PhD Jan Rehwinkel - Professor of Innate Immunology